Annalisa Jenkins, MD, is a life sciences thought leader with more than 25 years of biopharmaceutical industry experience. Jenkins served as president and CEO of Dimension Therapeutics, a leading NASDAQ-listed gene therapy company that was acquired by Ultragenyx in November 2017.

Laura Carstensen is a professor of psychology and the Fairleigh S. Dickinson Jr. professor in public policy at Stanford University, where she is the founding director of the Stanford Center on Longevity. In academia, Carstensen is known for socioemotional selectivity theory, a life-span theory of motivation.

A former California State treasurer with nearly two decades of experience as a senior bank executive, Kathleen Brown concentrates on business counseling, government, and regulatory affairs in connection with the health-care, energy, real estate, and financial services industries.

Alice Bonner has been a geriatric nurse practitioner caring for older adults and their families for over 30 years. She is currently adjunct faculty and director of strategic partnerships for the CAPABLE Program at the Johns Hopkins University School of Nursing and senior advisor for aging at the Institute for Healthcare Improvement.

Throughout her long career in science, Dr. Blackburn has been a leader in the area of telomere and telomerase research, having discovered the molecular nature of telomeres – the ends of eukaryotic chromosomes that serve as protective caps essential for preserving the genetic information – and co-discovered the ribonucleoprotein enzyme, telomerase. She is also known for her championing of diversity and inclusion in the sciences.

As the sixth managing partner in the 98-year history of Edward Jones, Penny Pennington is responsible for its strategic direction, working with more than 49,000 associates across North America to help 7 million clients achieve their financial goals. She was recently named to Barron’s inaugural 100 Most Influential Women in U.S. Finance and Fortune’s Most Powerful Women in Business lists.

Christopher Hite has advised hundreds of healthcare companies on projects ranging from mergers and acquisitions to capital formation. He has worked with some of the world’s leading companies, including Roche, GSK, Shire, Celgene, Astellas, and Johnson & Johnson.

Hon Pak, MD, is a seasoned corporate physician executive with over 25 years of health-care strategic leadership in health information technology across both public and private sectors.

Dr. Margaret Hamburg, President of the American Association for the Advancement of Science (AAAS), is an internationally recognized leader in public health, medicine and science. Dr. Hamburg is a former Commissioner of the U.S. Food and Drug Administration, known for advancing regulatory science, modernizing regulatory pathways, and globalization of the agency.

Sarita A. Mohanty, MD, serves as the president and CEO of the SCAN Foundation.